https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1396761/full
Frontiers | Sugemalimab combined with chemotherapy for the treatment of advanced esophageal...
Background:This study aims to systematically analyze the cost-effectiveness of the combination therapy comprising sugemalimab and chemotherapy in the managem...
for thefrontierssugemalimabcombinedchemotherapy
https://www.biospace.com/press-releases/cstone-submits-application-to-the-european-medicines-agency-for-new-indication-of-sugemalimab-in-stage-iii-non-small-cell-lung-cancer
CStone Submits Application to the European Medicines Agency for New Indication of Sugemalimab in...
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.1081750/full
Frontiers | Economic evaluation of first-line sugemalimab plus chemotherapy for metastatic...
ABSTRACTOBJECTIVE: To evaluate the economics of sugemalimab plus chemotherapy in the first-line treatment of metastatic non-small cell lung cancer, and to pr...
economic evaluationfirst linefrontiers